FABRAZYME® 35 mg
Powder for solution for infusion
registration number
46/31/0584
What FABRAZYME® 35 mg contains
Contains a nominal value of 35 mg of agalsidase beta. After reconstitution with 7,2 mL sterile water for injection, each vial contains 5 mg/mL (35 mg/7 mL) of agalsidase beta. After reconstitution with 1,1 mL sterile water for injection, each vial contains 5 mg/mL of agalsidase beta.
other ingredients
Mannitol
Sodium phosphate.
Therapeutic classification
A16AB04.